The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if we're talking about cardiovascular randomized trials with omega-3 that's where the heterogeneity is you're talking about uh yeah there's a lot of reasons why maybe over the last 10 years studies have not shown some studies have not shown an effect partly it's low dose partly its background omega-3 levels are higher in the population and they haven't controlled for that partly it's short-term treatment
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.